Skip to content
Research Article Open access CC BY 3.0

Ursodeoxycholic Acid (UDCA) in Biliary Diseases: A Clinical Review

Massimo Milani

Journal of Advances in Medicine and Medical Research · pp. 1783–1790 · Published 9 Jan 2014

10.9734/BJMMR/2014/7186

Abstract

Ursodeoxycholic acid (UDCA) is an established and accepted treatment of biliary diseases such as gallstones and primary biliary cirrhosis. Mechanisms of action of UDCA are not so far completely elucidated. UDCA tablets are indicated for the dissolution of small to medium sized radiolucent, cholesterol-rich gall-stones in patients with a functioning gall bladderand in the treatment of primary biliary cirrhosis (PBC). The Food and Drug Administration's Gastrointestinal Drugs Advisory Committee has stated that UDCA is safe and effective for the treatment of primary biliary cirrhosis. More recent Meta-analysis have cast doubt on the real impact of UDCA in patients with PBC. However more recent articles and systematic reviews have pointed out that the risk of death or liver transplantation was reduced by 32% in PBC patients treated with UDCA compared to placebo. In this review we summarized the principal evidence of efficacy of UDCA in the treatment of biliary diseases. UDCA remains so far a relevant pharmacological treatment in biliary diseases.

Ursodeoxycholic biliary diseases review.

Cited by 14

Novel insights into bexarotene's role in preventing cholestasis: mechanisms and implications

Thamer Abdulla Mohammed, M. H. Zalzala · Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.

J. Golden, Oswaldo H. Escobar, Michelle V. L. Nguyen · American Journal of Physiology - Gastrointestinal and Liver Physiology · 2018

A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis

Peiying Zuo, R. Dobbins, R. O'Connor-Semmes · CPT: Pharmacometrics & Systems Pharmacology · 2016

Pharmacodynamic and pharmacokinetic aspects of combined use of glycyrrhizinic acid

V. A. Prikhodko, S. V. Okovityi · Experimental and Clinical Gastroenterology · 2023

Showing 6 of 14 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

0

Outbound clicks

14

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.